Oragenics (OGEN) said Wednesday that it closed its $16.5 million public offering of series H convertible preferred stock and warrants.
The offering includes 660,000 shares of series H convertible preferred stock along with warrants to buy up to an equal number of series H convertible stock, according to the company.
Oragenics sold each unit, consisting of one preferred share and one warrant, at $25 a piece.
Each warrant can be exercised at $25 per share and expires after five years, the company added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.